Pain

In a dose finding trial, 100 μg of sprifermin every 6 or 12 months is proven to boost femorotibial joint cartilage thickness in patients suffering from osteoarthritis.

The monoclonal antibody class of drugs could help osteoporosis patients prevent fractures.

Recent measures in the UK has led to a drop in IBD patients using corticosteroids to excess.

In a new trial, investigators test whether continuing or discontinuing ADA is more beneficial.

In a new randomized study, investigators compare 2 hip surgeries for elderly patients with a displaced femoral neck fracture.

The largest improvements for patients taking ustekinumab occurred following treatment every 8 weeks.

Sheetal Desai, MD, AWARE investigator and assistant clinical professor of medicine at UC Irvine, discusses full 52-week results of study comparing 2 popular rheumatoid arthritis patients and what the observed safety profile means from a patient-centered perspective.

The Proclaim XR recharge-free system provides relieve through a low-dose proprietary BurstDR stimulation waveform, which mimics natural brainwave patterns that change pain signals traveling from the spinal cord to the brain.

In an intervention study, investigators try to show whether vitamin D deficiency interferes with slowing muscle wasting and losing function in geriatric adults.

At the annual meeting dedicated to heart failure, investigators present nutritional recommendations for patients, which includes dietary consultations, bariatric surgery, and a reduction in saturated fats and sodium.

There are many options to treat heart failure for patients suffering from end stage kidney disease.

In a presentation at the annual HFSA meeting, investigators compare the level of care and ultimate outcomes treating heart failure patients for cardiologists and non-cardiologists.

At the annual HFSA meeting, investigators explain how obstructed sleep apnea and central sleep apnea drive cardiovascular disease.

A pair of new mesh products will optimize hernia surgery, while reinforcing soft tissue with twice the strength.

Through clinical trials, investigators find that SGLT2 inhibitors are not only safe, but have several cardiovascular benefits.

After success in multiple clinical trials, officials tout esketamine as a treatment for both major depressive disorder with active suicidal ideation and treatment resistant depression.

A recent review of adverse event reports from the FDA found that tramadol use was associated with a tenfold greater risk of developing hypoglycemia than most other opioids.

The Tether-Vertebral Body Tethering System will help treat the most common form of idiopathic scoliosis.

Drinking more than 3 servings of caffeinated beverages per day was associated with an increase in migraine headaches.

FDA announces 137 new drug approvals in 2018 represents an 11% increase over 2017.

Older patients could benefit from skipping traditional bedrest in favor of an exercise program when hospitalized with an acute illness.

A recent study of more than 200,000 injured workers identified risk factors of opioid use of a previously opioid-free population.

The Erchonia Corp. product reportedly reduced patient pain by nearly 50% in clinical trials.

Combination of ibuprofen and Percocet found to reduce patient opioid consumption following surgery compared to receiving opioids alone.

Investigators found that galcanezumab reduced frequency of cluster headache attacks and had no substanial differences in adverse events when compared to placebo.

For chronic pain sufferers using opioids, policy changes have made it difficult to find new primary care providers — which investigators warn could have unintended consequences.

Rimegepant (rimegepant Zydis), which is a novel therapy for treatment of acute migraines, was found to reduce bothersome suymptoms and eliminate pain in a phase 3 clinical trial.

A recent study found that 65% of adult users reported using cannabis for pain relief and 88% of those taking opioid analgesics reported reducing or discontinuing use of medications.

An all-star team of physicians give their takes on how the science behind keeping million dollar athletes on the field has impacted the care patients receive every day.

Contrary to earlier research, investigators found that medical cannabis laws do not reduce deaths caused by opioid overdoses.